News
Aidixi plus BCG showed strong early efficacy and manageable safety in patients with high-risk, HER2-expressing non–muscle-invasive bladder cancer.
Menopause can bring about a whole host of changes for women, from physical side effects to emotional symptoms, there can be a ...
The menopause transition is often accompanied by a wide array of symptoms, some of which receive more attention than others.
The menopause transition is often accompanied by a wide array of symptoms, some of which receive more attention than others.
AUA annual meeting featured the IBCG Bladder Cancer Forum evaluating common problems and controversies in bladder cancer, moderated by Dr. Peter Black, with a debate between Drs. Wes Kassouf and ...
In a study from Dr. Zlotta’s group published in 2025 in the Journal of Urology, 1 they suggest that better tools are needed to minimize interobserver variability in pathological grading. This is ...
Sumitomo Pharma America, Inc. (SMPA) presented new, positive data from the COURAGE Phase 3 open-label extension study of vibegron (GEMTESA®) in men living with overactive bladder (OAB) and receiving ...
Researchers will present their study findings covering important updates on women's and children's health from April 26 to 29. Wai Lee, MD, a urogynecologist with Northwell Health, posed in-depth ...
UTIs are uncomfortable and sometimes serious, but they are also largely preventable. By understanding the risks, especially ...
Results from the Phase IIb SunRISe-1 study demonstrated a one-year duration of response with the TAR-200 intravesical ...
If you've got a manual on USB ports or have watched any kind of video, you may have heard them referred to as Male or Female ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results